Distinct Effects of Stereotactically Injected Human Cerebrospinal Fluid Containing Glutamic Acid Decarboxylase Antibodies Into the Hippocampus of Rats on the Development of Spontaneous Epileptic Activity

Brain Sciences - Switzerland
doi 10.3390/brainsci10020123
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

MDPI AG

Related search

Anti–Glutamic Acid Decarboxylase Antibodies in the Serum and Cerebrospinal Fluid of Patients With Stiff-Person Syndrome

Archives of Neurology
2004English

Effects of Anti-Glutamic Acid Decarboxylase Antibodies Associated With Neurological Diseases

Annals of Neurology
Neurology
2007English

Cerebellar Ataxia With Anti–Glutamic Acid Decarboxylase Antibodies

Archives of Neurology
2001English

Diabetes Mellitus and Ataxia With Anti-Glutamic Acid Decarboxylase Antibodies

Endocrine Abstracts
2016English

Physicochemical Studies on the Active Site of Glutamic Acid Decarboxylase

English

Ribonuclease Activity of Human Cerebrospinal Fluid

Canadian Journal of Neurological Sciences
MedicineNeurology
1977English

Absence of Glutamic Acid Decarboxylase Antibodies in Pima Indian Children With Diabetes Mellitus

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1999English

Epilepsy and Cerebellar Ataxia Associated With Anti-Glutamic Acid Decarboxylase Antibodies

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2007English

Clinical Management of Epilepsy With Glutamic Acid Decarboxylase Antibody Positivity: The Interplay Between Immunotherapy and Anti-Epileptic Drugs

Frontiers in Neurology
Neurology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy